Publication | Closed Access

Patient-centred outcomes and effect of disease progression on health status in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation receiving maintenance olaparib or placebo (SOLO1): a randomised, phase 3 trial

Maintenance OlaparibOncologyBrca MutationCancer ManagementClinical TrialsGynecologyOutcomes ResearchPatient-centred OutcomesPatient-reported OutcomeCancer TreatmentMedicineGynecology OncologyOvarian Cancer